Sylvia K.
- Country
- The Netherlands
- Department
- Children Rheumatology
Research Overview
Data & Insights
Has run more than one trial at 1 of 9 partner sites.
Specializations
Rheumatology & Autoimmune Disorders
This investigator specializes in the treatment of systemic juvenile idiopathic arthritis (sJIA), with particular focus on developing innovative therapeutic approaches for pediatric patients. Their research encompasses the management of autoimmune disorders affecting children's joints and systemic inflammation.
- Systemic JIA Treatment Optimization
- Pediatric Rheumatology
- Autoimmune Disease Management
The investigator's work centers on improving treatment protocols for children with Still's disease through biomarker-guided therapy approaches.
Biomarker Research
The investigator focuses on the application of biological markers in treatment decision-making, particularly studying IL-18 as a key indicator for therapeutic response. Their work aims to enhance precision medicine approaches in pediatric autoimmune conditions.
- Inflammatory Biomarkers
- Treatment Response Indicators
- Personalized Medicine Approaches
Their expertise includes utilizing biomarkers to guide targeted treatment strategies and optimize therapeutic interventions.
Pediatric Medicine
The investigator specializes in pediatric inflammatory conditions, focusing on developing treatment strategies that are both effective and appropriate for young patients. Their research emphasizes the importance of precise therapeutic interventions in childhood autoimmune disorders.
- Childhood Inflammatory Diseases
- Pediatric Treatment Protocols
- Early Intervention Strategies
Their work involves optimizing treatment duration and intensity for pediatric patients with systemic inflammatory conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.